Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sapropterin for portal hypertension in liver cirrhosis
2010-024651-86Phase 2Active
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jan 2012
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Portal Hypertension (PH) and Cirrhosis comparing Sapropterin with Placebo (2 arms). Started Jan 2012; status: active.
02
Drugs
sapropterin
03
Conditions
Portal Hypertension (PH)Cirrhosis
Beyond the preview
Go deeper on 2010-024651-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024651-86.